Organigram Global (OGI) Asset Utilization Ratio (2019 - 2026)

Organigram Global (OGI) reported Asset Utilization Ratio of 0.55 for Q1 2026, up 16.84% quarter-over-quarter from 0.47 in Q4 2025.

Organigram Global (OGI) Asset Utilization Ratio (2019 - 2026) Analysis & Trends

Organigram Global (OGI) has 5 years of Asset Utilization Ratio data on file, last reported at 0.55 in Q1 2026.

Asset Utilization Ratio for Q1 2026 came in at 0.55, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.55 (changed N/A YoY), and the FY2025 annual result was 0.51, changed N/A from the prior year.
Asset Utilization Ratio advanced to 0.55 in Q1 2026 per OGI's latest filing, from 0.47 in the prior quarter.
Over five years, Asset Utilization Ratio peaked at 0.55 in Q1 2026 and troughed at 0.47 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	0.43
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	0.62
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	0.43
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	0.48
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	0.65
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	0.37
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	0.36
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	1.07
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	0.68
10	Organigram Global	731.20 Mn	673.26 Mn	11.96 Mn	0.55

Download Data